Clear Cell Adenocarcinoma of the Urethra: Review of the Literature

Figure 13

This figure shows immunoreactivity of cytokeratin (CK) 7, CK 20, K903, and p63 in clear cell adenocarcinoma. (a) Positive staining with CK7 (bladder, case 1). (b) Focally positive staining with CK20 (bladder, case 1). (c) Positive staining with CK 7 (urethra, case 3). (d) Negative staining with CK 20 (urethra, case 3). (e) Positive staining with K 903 (bladder, case 2). (f) Negative staining with p63 (bladder, case 2). Immunoperoxidase, original magnification ×200 ((a) to (e)) and ×100 (f). Reprinted from [8] Sun et al. Clear cell adenocarcinoma of the urinary bladder and urethra: another urinary tract lesion immunoreactive for P504S. Arch Pathol Lab Med 2008 Sep; 132(9): 1417–1422 reprinted with permission from Archives of Pathology and Laboratory Medicine Copyright 2008 College of American Pathologists. This permission is exclusive to this request specifically for this paper. Additional usage of any printed or electronic material for which the Archives of Pathology and Laboratory Medicine owns copyright would require permission from the editorial office.

(a)

(b)

(c)

(d)

(e)

(f)